|
|
|
|
|
|
HIPAA Compliance: Hospital Strategies for Meeting Tough New Requirements
|
|
Our Price: $199.00
|
|
|
Available Now!
Sweeping changes to the HIPAA Privacy and Security Rules now give the Office of Civil Rights (OCR) the power to enforce HIPAA privacy and security protections among payers, providers, vendors, business associates, and their subcontractors! Effective immediately, the HIPAA Omnibus Rule makes all parties at risk for violating protected health information. And penalties are severe, capping out at $1.5 million per violation!
|
|
|
|
|
|
|
|
|
|
CDIP for ICD-10-CM: Laying the Groundwork
|
|
Our Price: $199.00
|
|
|
Available Now!
Increased
documentation requirements are without doubt one of the top provider
concerns surrounding the ICD-10 training and readiness. But don't take
our word for it. In a recent survey conducted by ICD10monitor, 62% of
the participants in their Talk Ten Tuesday
radio program cited CDI as to their most vulnerable area related to
ICD-10. This is not surprising given the increased documentation
requirements inherent in the transition from ICD-9 to ICD-10.
|
|
|
|
|
|
|
|
|
|
Obtaining Part B Payment When Part A is Denied: Understanding the Impact on Reimbursement
|
|
Our Price: $199.00
|
|
|
Available Now!
The Centers for Medicare & Medicaid Services have issued an Administrative Ruling on hospital reimbursement on Part B claims when Part A claims have been denied. That ruling which appears to have a positive affect on providers is effective immediately. At the same time, CMS has issued a proposed rule that appears to contradict its own ruling and could significantly impact your reimbursement.
|
|
|
|
|
|
|
|
|
|
Fluoroscopy Services: Reduce Your Coding & Billing Risks
|
|
Our Price: $209.00
|
|
|
Available Now!
Fluoroscopy has numerous diagnostic and therapeutic applications. Each of these areas seems to come with its own set of coding and billing rules which helps explain why so many facilities submit claims with erroneous charges for fluoroscopy services.
|
|
|
|
|
|
|
|
|
|
Outpatient Infusion & Injection Services: The Link Between Documentation and Risk
|
|
Our Price: $209.00
|
|
|
Available Now!
Every day, hospitals across the U.S. deliver an enormous volume of outpatient infusions and IV push injections. And every day, many of these hospitals routinely overcharge or undercharge for infusions and injections.
|
|
|
|
|
|
|
|
|
|
How to Mitigate Your Hospitals Pharmacy Audit Risks and Avoid Overpayments
|
|
Our Price: $209.00
|
|
|
Available Now!
In the last four months alone, the OIG has released 11 audit reports that target hospital billing patterns for outpatient drugs the result identification of nearly $12 million overpayments. These overpayments were directly related to incorrect application and reporting of billing unit multipliers (billable units), lack of supporting medical necessity and poor system controls at the contractor or provider level. Widely used pharmaceuticals including Herceptin, Remicade and Lupron are being targeted by the OIG, so ramifications could be severe if your claims are not accurate.
|
|
|
|
|
|
|
|
|
|
Implantable Devices: How to Avoid Massive Fines Being Levied by the OIG
|
|
Our Price: $199.00
|
|
|
Available Now!
Hospitals
and ASCs face increasing audit risk by the Office of Inspector General (OIG)
for services that involve implantable devices. This crackdown has resulted in
facilities having to repay hundreds of thousands of dollars in fines. Under IPPS and OPPS, as well as ASCs, facilities must follow accurate device-credit
reporting, including amounts of manufacturer/vendor credits as well as device credit
modifiers and condition codes.
Don't risk OIG action or hefty payments! Learn the rules and get a system in place to
handle these protocols.
|
|
|
|
|
|
|
|
|
|
Medicare Appeals & Reimbursement Impacted by New OIG Report
|
|
Our Price: $199.00
|
|
|
Be prepared. The recent report released by the
Office of Inspector General suggesting improvements to the ALJ level of
Medicare appeals will likely impact your appeals. During this crucially
important webcast, you'll learn why you'll need to re-examine your appeal
strategies in light of the OIG recommendations.
|
|
|
|
|
|
|
|
|
|
Laboratory Preventive Care Services: Avoiding Costly Payment Denials
|
|
Our Price: $209.00
|
|
|
Available Now!
During the first six months
of 2012, more than 16 million people with original Medicare received at least
one service covered under the Affordable Care Act's expanded benefits for
preventive services, according to CMS. What does this mean for physicians who provide
these services?
|
|
|
|
|
|
|
|
|
|
Discharge Summary Strategies to Improve Compliance & Reduce Hospital Readmissions
|
|
Our Price: $199.00
|
|
|
Nowhere in the continuum of care is there a
greater threat of vulnerability than at the time of discharge. Breakdown in
communication as a result of an incomplete discharge summary can set off an
adverse chain of events, including heightened readmission rates a target
being aggressively tracked by recovery auditors. During this essential webcast, you'll learn how to generate a clinically relevant, fully compliant discharge
summary that embraces best practices using an evidence-based approach. |
|
|
|
